GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Classificação em ações
#3671
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Preço da ação
$27.17
Valor de mercado
$4.60B
Variação (1 dia)
-1.33%
Variação (1 ano)
-13.30%
País
IN
Negociar GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Categoria
Healthcare
Rácio P/S de GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Rácio P/S em October 2026 TTM: 10.72
De acordo com os relatórios financeiros mais recentes e o preço das ações da GlaxoSmithKline Pharmaceuticals Limited, o rácio P/S atual (TTM) é 10.72. No final de 2024, o rácio P/S era 9.74.
Histórico do rácio P/S da GlaxoSmithKline Pharmaceuticals Limited de 2004 a 2026
Rácio P/S no final de cada ano
| Ano | Rácio P/S | Alterar |
|---|---|---|
| 2026 (TTM) | 10.72 | -15.16% |
| 2025 | 12.64 | 29.73% |
| 2024 | 9.74 | 41.17% |
| 2023 | 6.90 | -19.88% |
| 2022 | 8.61 | 3.26% |
| 2021 | 8.34 | 26.28% |
| 2020 | 6.61 | -6.14% |
| 2019 | 7.04 | 13.41% |
| 2018 | 6.21 | -22.36% |
| 2017 | 7.99 | -31.64% |
| 2016 | 11.69 | 6.32% |
| 2015 | 11.00 | 10.60% |
| 2013 | 9.94 | 43.71% |
| 2012 | 6.92 | -0.12% |
| 2011 | 6.93 | -24.74% |
| 2010 | 9.20 | 28.61% |
| 2009 | 7.16 | 24.35% |
| 2008 | 5.76 | 6.38% |
| 2007 | 5.41 | -12.92% |
| 2006 | 6.21 | -1.99% |
| 2005 | 6.34 | 32.89% |
| 2004 | 4.77 | 0.00% |
Rácio P/S de empresas semelhantes ou concorrentes
| Empresa | Rácio P/S | Diferença do rácio P/S | País |
|---|---|---|---|
| 14.32 | 33.54% |
US
|
|
| 6.16 | -42.56% |
US
|
|
| 7.78 | -27.45% |
US
|
|
| 5.48 | -48.88% |
US
|
|
| 4.66 | -56.56% |
CH
|
